To independently test whether complete loss of lmo1 expression confers protection against the development of neuroblastoma, we used CRISPR-Cas9–mediated gene editing to generate a lmo1 knockout allele containing a 32 bp deletion of coding sequences in the second exon that led to premature termination of translation (Supplemental Figure 4). This evidence concerns the gene LMO1 and neuroblastoma.